AGL 38.14 Increased By ▲ 0.12 (0.32%)
AIRLINK 215.29 Increased By ▲ 17.93 (9.08%)
BOP 9.84 Increased By ▲ 0.30 (3.14%)
CNERGY 6.66 Increased By ▲ 0.75 (12.69%)
DCL 9.19 Increased By ▲ 0.37 (4.2%)
DFML 38.20 Increased By ▲ 2.46 (6.88%)
DGKC 101.00 Increased By ▲ 4.14 (4.27%)
FCCL 36.50 Increased By ▲ 1.25 (3.55%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 14.49 Increased By ▲ 1.32 (10.02%)
HUBC 134.20 Increased By ▲ 6.65 (5.21%)
HUMNL 13.70 Increased By ▲ 0.20 (1.48%)
KEL 5.70 Increased By ▲ 0.38 (7.14%)
KOSM 7.29 Increased By ▲ 0.29 (4.14%)
MLCF 45.45 Increased By ▲ 0.75 (1.68%)
NBP 61.40 Decreased By ▼ -0.02 (-0.03%)
OGDC 232.70 Increased By ▲ 18.03 (8.4%)
PAEL 40.95 Increased By ▲ 2.16 (5.57%)
PIBTL 8.55 Increased By ▲ 0.30 (3.64%)
PPL 204.50 Increased By ▲ 11.42 (5.91%)
PRL 40.05 Increased By ▲ 1.39 (3.6%)
PTC 28.36 Increased By ▲ 2.56 (9.92%)
SEARL 108.19 Increased By ▲ 4.59 (4.43%)
TELE 8.72 Increased By ▲ 0.42 (5.06%)
TOMCL 35.92 Increased By ▲ 0.92 (2.63%)
TPLP 13.89 Increased By ▲ 0.59 (4.44%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 34.75 Increased By ▲ 1.78 (5.4%)
WTL 1.71 Increased By ▲ 0.11 (6.88%)
BR100 12,247 Increased By 520.9 (4.44%)
BR30 38,316 Increased By 1938.9 (5.33%)
KSE100 114,070 Increased By 4557.3 (4.16%)
KSE30 36,084 Increased By 1570.7 (4.55%)
Markets

European stocks end lower on virus, policy jitters

  • German consumer morale darkens: GfK
  • Travel stocks fall on virus woes
  • Swedish Orphan Biovitrum tops STOXX 600
Published August 26, 2021

European shares ended lower on Thursday after data showed faltering German consumer morale amid rising COVID-19 cases, while investors fretted over US monetary policy ahead of the Jackson Hole symposium.

The pan-European STOXX 600 index fell 0.3%, with mining and travel & leisure stocks leading losses.

The STOXX 600 had briefly deepened its losses towards the close, tracking a fall in US stocks after sentiment was rattled by a blast in Kabul.

Anticipation of the US Federal Reserve's annual Jackson Hole summit on Friday kept investors on their toes, with chair Jerome Powell's speech likely to offer hints on the central bank's plans to taper its massive stimulus programme.

"We think that those expecting clear communication about the shape and timing of the tapering of asset purchases may be disappointed," said Paolo Zanghieri, senior economist at Generali Investments. "The recent data remain strong, but momentum is receding and inflation fears have not surged."

Blast outside Kabul airport kills at least 13, including children: Taliban official

A survey showed the mood among German consumers darkened heading into September as accelerating inflation and rising COVID-19 cases made them more hesitant to buy.

Business morale in the euro zone's largest economy fell for the second month running in August, data on Wednesday showed.

"Risks are tilted to the downside over the near term," analysts at BCA Research said. "While global COVID-19 cases appear to be rolling over and (China's) Ningbo-Zhoushan port has reopened, which are both positive for supply chains, COVID-19 cases are still climbing in Germany."

European travel company Tui, airlines Wizz Air , Lufthansa and British Airways-owner IAG fell by between 0.9% and 3.8%.

Wizz Air was the worst performer on the STOXX 600, dropping 3.8%.

Germany's blue-chip DAX dropped 0.4%, marking its lowest closing level in a week, while the UK's FTSE 100 and France's CAC 40 declined by 0.4% and 0.2%, respectively.

Deutsche Bank's asset management arm DWS Group fell 13.7% on a report US authorities were investigating DWS over sustainability claims. Deutsche Bank's shares dropped 1.5%.

France's Vivendi rose 2.6% after its unit Universal Music Group said it expects further revenue growth this year and it aims to pay out dividends once it lists in Amsterdam.

French conglomerate Bouygues gained 1.1% as it raised its full-year earnings outlook.

Swedish Orphan Biovitrum was the best performer on the STOXX 600, rising 8.8% after Bloomberg reported that private equity firm Advent International is considering a bid for the pharmaceutical maker.

Comments

Comments are closed.